Matches 1 - 30 out of 30


Match Document Document Title Score
US20140057849 WILD-TYPE APOLIPOPROTEIN L-I FOR USE IN THE PREVENTION OF KIDNEY DISEASES  
A wild-type human Apolipoprotein L-I is used in a method for the prevention and/or the treatment of renal disease.
1000
9119817 Wild-type apolipoprotein L-I for use in the prevention of kidney diseases  
A wild-type human Apolipoprotein L-I is used in a method for the prevention and/or the treatment of renal disease.
1000
EP2489365A1 Wild-type apolipoprotein L-I for use in the prevention of kidney diseases  
The present invention is related to wild-type human Apolipoprotein L-I for the prevention and/or the treatment of renal disease.
1000
WO/2012/110625A1 WILD-TYPE APOLIPOPROTEIN L-I FOR USE IN THE PREVENTION OF KIDNEY DISEASES  
The present invention is related to wild-type human Apolipoprotein L-I for the prevention and/or the treatment of renal disease.
1000
US20090162333 PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES  
A pharmaceutical composition has an adequate pharmaceutical carrier or diluent and an element selected from a pharmaceutical composition having an adequate pharmaceutical carrier or diluent and an...
946
EP1867338A1 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases  
The present invention is related to a pharmaceutical composition comprising an adequate pharmaceutical carrier or diluent and an element selected from the group consisting of: - apolipoprotein...
946
EP2029158A1 PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES  
The present invention is related to a pharmaceutical composition comprising an adequate pharmaceutical carrier or diluent and an element selected from the group consisting of: - apolipoprotein...
946
WO/2007/138023A1 PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES  
The present invention is related to a pharmaceutical composition comprising an adequate pharmaceutical carrier or diluent and an element selected from the group consisting of a pharmaceutical...
946
WO/2002/019960A2 PURIFICATION, CHARACTERIZATION AND USE OF PROTECTIVE ANTIGENIC STRUCTURES AGAINST TRYPANOSOMES AND RELATED PARASITES  
The present invention is related to a method for the recovering and the characterization of a surface antigenic structure of a trypanosome flagellar pocket (fp), characterized in that it comprises...
946
US20180185461 TREATMENT AND DETECTION OF TRYPANOSOMES  
The present invention relates to methods and compositions for preventing, treating and diagnosing infection by trypanosomes. The invention also relates to the use of excreted/secreted antigens...
848
US20190388524 TREATMENT AND DETECTION OF TRYPANOSOMES  
The present invention relates to methods and compositions for preventing, treating and diagnosing infection by trypanosomes. The invention also relates to the use of excreted/secreted antigens...
848
US20150011735 APOLIPOPROTEIN L-I VARIANTS AND THEIR USE  
The present invention is related to an isolated human Apolipoprotein L-I corresponding to this wild type human Apolipoprotein sequence modified by a deletion at its C-terminal end.
848
US20120128682 APOLIPOPROTEIN L- I VARIANTS AND THEIR USE  
An isolated human Apolipoprotein L-I corresponding to a wild type human Apolipoprotein sequence is modified by a deletion at its C-terminal end.
848
EP2470658A1 APOLIPOPROTEIN L- I VARIANTS AND THEIR USE  
An isolated human Apolipoprotein L-I corresponding to a wild type human Apolipoprotein sequence is modified by a deletion at its C-terminal end.
848
EP3297648A1 TREATMENT AND DETECTION OF TRYPANOSOMES   848
WO/2012/095508A1 APOL3 FOR USE IN THE TREATMENT OF TRYPANOSOMA INFECTIOUS DISEASES  
The present invention is related to a pharmaceutical composition comprising (human) ApoL-3- derived protein(s), especially for use in the treatment or the prevention of Trypanosoma Sp. Infection.
848
WO/2011/020497A1 C-TERMINAL MUTANT OF APOLIPOPROTEIN L-I AND ITS THERAPEUTICAL OR PROPHYLACTIC USE  
The present invention is in the field of Molecular Biology and is related to new c-terminal mutants of Apolipoprotein L-I and their pharmaceutical use especially for a treatment and/or a...
848
WO/2016/185135A1 TREATMENT AND DETECTION OF TRYPANOSOMES  
The present invention relates to methods and compositions for preventing, treating and diagnosing infection by trypanosomes. The invention also relates to the use of excreted/secreted antigens...
848
WO/2011/020865A1 APOLIPOPROTEIN L- I VARIANTS AND THEIR USE  
The present invention is related to an isolated human Apolipoprotein L-I corresponding to this wild type human Apolipoprotein sequence modified by a deletion at its C-terminal end.
848
US20060263348 Apolipoprotein l-i and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma  
The present invention is related to a composition comprising apolipoprotein L-1, the use of apolipoprotein L-1 or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
7585511 Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma  
The present invention is related to a composition comprising apolipoprotein L-l, the use of apolipoprotein L-l or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
EP1534320A2 APOLIPOPROTEIN L-I FOR THE TREATMENT OR DIAGNOSIS OF TRYPANOSOMAL DISEASES  
Abstract not available for EP1534320 Abstract of corresponding document: WO2004012757 The present invention is related to a composition comprising apolipoprotein L-I, the use of apolipoprotein L-I...
768
EP1534320B1 APOLIPOPROTEIN L-I FOR THE TREATMENT OF TRYPANOSOMAL DISEASES  
Abstract not available for EP1534320 Abstract of corresponding document: WO2004012757 The present invention is related to a composition comprising apolipoprotein L-I, the use of apolipoprotein L-I...
768
WO/2004/012757A3 APOLIPOPROTEIN L-I FOR THE TREATMENT OR DIAGNOSIS OF PRYPANOSOMALDISEASES  
The present invention is related to a composition comprising apolipoprotein L-I, the use of apolipoprotein L-I or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
WO/2004/012757A2 APOLIPOPROTEIN L-I FOR THE TREATMENT OR DIAGNOSIS OF PRYPANOSOMALDISEASES  
The present invention is related to a composition comprising apolipoprotein L-I, the use of apolipoprotein L-I or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
DE60309888D1 APOLIPOPROTEIN L-I ZUR BEHANDLUNG VON TRYPANOSOMEN-ERKRANKUNGEN  
The present invention is related to a composition comprising apolipoprotein L-l, the use of apolipoprotein L-l or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
DE60309888T2 APOLIPOPROTEIN LI FOR THE TREATMENT OF DISEASES trypanosome  
The present invention is related to a composition comprising apolipoprotein L-l, the use of apolipoprotein L-l or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of...
768
WO/2009/124941A3 TRYPANOCIDAL COMPOUNDS TARGETED TO TRYPANOSOMES INTERIOR  
Drugs conjugates and methods for targeting toxic compounds to the interior of trypanosomes, including trypanosomes causing trypanosomiasis, also known as sleeping sickness. The drug conjugates...
655
WO/2009/124941A2 TRYPANOCIDAL COMPOUNDS TARGETED TO TRYPANOSOMES INTERIOR  
Drugs conjugates and methods for targeting toxic compounds to the interior of trypanosomes, including trypanosomes causing trypanosomiasis, also known as sleeping sickness. The drug conjugates...
655
US20210019163 MANAGED VIRTUAL APPLIANCES  
Disclosed are various embodiments for creating and managing virtual appliances. A command to create a virtual machine image for a hosted instance of an application image is received. The virtual...
582

Matches 1 - 30 out of 30
« search again